Renal Denervation Devices Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034
Discover trends, market shifts, and competitive outlooks for the renal denervation devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Renal Denervation Devices Market From 2025 To 2029?
The market for renal denervation devices has seen significant expansion in the past few years. The market is projected to increase from $0.55 billion in 2024 to $0.74 billion in 2025, with a compound annual growth rate (CAGR) of 34.0%. Factors contributing to historical growth include an uptick in hypertension instances, thorough clinical research and studies, a rise in cardiovascular diseases, early approval from the FDA, and advancements in regulations, as well as the market introduction of renal denervation systems.
It is anticipated that the market size for renal denervation devices will experience a significant expansion in the coming years. The market is predicted to escalate to “$2.28 billion by 2029, growing at a compound annual growth rate (CAGR) of 32.3%. The expected surge during the forecast period can be credited to factors such as a patient-centric perspective, enhancements in healthcare infrastructure, rising acceptance and awareness, targeted minimally invasive treatments, and the introduction of new devices to the market. Notable future trends encompass the incorporation of artificial intelligence (AI) and machine learning, alterations in the regulatory environment, a transition towards minimally invasive procedures, an emphasis on clinical evidence, and the integration of remote monitoring and telehealth.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10631&type=smp
What External and Internal Drivers Are Contributing to the Growth of theRenal Denervation Devices Market?
The growth of the renal denervation devices market is expected to be propelled forward by the rising incidence of hypertension. Hypertension, colloquially referred to as high blood pressure, is a persistent condition characterised by an excessively high force exerted by the blood as it flows through the vessels. Renal denervation has come to the forefront as a viable therapeutic method for patients suffering from resistant hypertension. It is a minimally invasive procedure under investigation for the treatment of hypertension that hasn’t shown a positive response to medical intervention. For instance, data from the Centers for Disease Control and Prevention, a US governmental body, revealed that in 2022, high blood pressure was a contributing factor or the direct cause of the death of 685,875 Americans. Hence, the renal denervation devices market is likely to expand due to the growing prevalence of hypertension.
What Segment Types Define the Renal Denervation Devices Market Structure?
The renal denervation devices market covered in this report is segmented –
1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products
2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Brachytherapy, Chemical Ablation, Other Technologies
3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users
Subsegments:
1) By Simplicity Renal Denervation System: Catheter System, Accessories
2) By EnligHTN: Catheter System, Generator, Accessories
3) By Vessix Renal Denervation System: Balloon Catheter, Generator, Accessories
4) By Iberis Renal Sympathetic Denervation System: Catheter System, Accessories
5) By Paradise Renal Denervation System: Catheter System, Accessories
6) By Other Products: Emerging Technologies, Alternative Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=10631&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Renal Denervation Devices Market?
Europe was the largest region in the renal denervation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Renal Denervation Devices Market?
Key players in the renal denervation devices market are shifting their focus towards the creation of ultrasound renal denervation (uRDN) tools. The goal behind this is to improve treatment effectiveness, decrease the occurrence of procedural issues, and introduce a non-invasive substitute for traditional renal denervation procedures. uRDN enhances renal denervation devices by allowing safe, non-invasive energy transmission to renal nerves. As a result, it manages to decrease blood pressure effectively while safeguarding surrounding tissues and increasing the safety and comfort of patients during the procedure. For instance, Recor Medical Inc., a medical technology firm based in the US, introduced the Paradise uRDN system in November 2023. This pioneering ultrasound renal denervation device is crafted to manage hypertension in patients unable to attain blood pressure targets through standard lifestyle modifications and medication. Equipped with hydrocooling technology to safeguard the renal artery during treatment, this system signifies a substantial progression in the renal denervation devices market. It brings forth a fresh, nonpharmacologic method to tackle resistant hypertension and broadens the treatment choices for patients.
View the full report here:
https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report
What Is the Definition of the Renal Denervation Devices Market?
Renal denervation devices are minimally invasive medical devices used to treat hypertension (high blood pressure) that have not improved with other treatments. A catheter is passed into the renal arteries that ablate sympathetic nerves in the vessel wall using radiofrequency energy to allow greater blood flow to the kidneys.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10631
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
